Lilly Buys Psychedelics Maker Atai Beckley for $2.8B
Eli Lilly unveils a landmark $2.8 billion cash deal to acquire Atai Beckley, aiming to push a DMT-like therapy for tr...
Comparison of dominant fund strategies for retirement, weighing SP 500 versus Total Market to guide your decision.
28,607 articlesEli Lilly unveils a landmark $2.8 billion cash deal to acquire Atai Beckley, aiming to push a DMT-like therapy for tr...
As travel rebounds, premium demand is reshaping cruise stock dashboards. This deep dive explains why norwegian cruise...
Ethereum-focused ETFs faced a heavy outflow spell, totaling $708 million over 14 sessions, while XRP and Solana poste...
AI-first cloud services are redefining how businesses run. This article breaks down the neocloud revolution here. thi...
Rocket Lab has unveiled a bold $8 billion move by announcing a plan to acquire Iridium. This article breaks down what...
An ETF-based approach blends residential and mortgage REITs to generate passive income without property management. A...
Quantum computing is still in its early innings, and Rigetti Computing sits at a pivotal crossroads. This article bre...
The Trade Desk faced another slide as investors weighed AI-driven competition and fee pressure. This deep dive breaks...
A major family-office investor has increased its position in Middleby as the company prepares a spin-off. This move o...
A bold AI experiment in Argentina aimed at reshaping public policy stumbled on human error and bad data. The fallout ...
Avis Budget Group stock surged this week as travel demand picked up and airport bottlenecks nudged customers toward r...
June markets stay choppy as Aurora Innovation slides on Uber stake actions. This guide breaks down what it means for ...